Abstract:Background: The high metastasis and mortality rates of head and neck squamous cell carcinoma (HNSCC) urgently require new treatment targets and drugs. A steroidal component of ChanSu, telocinobufagin (TBG), was verified to have anti-cancer effects in various tumors, but its activity and mechanism in anti-HNSCC were still unknown. Purpose: This study tried to demonstrate the anti-tumor effect of TBG on HNSCC and verify its potential mechanism. Methods: The effect of TBG on cell proliferation and metastasis were performed and the TBG changed genes were detected by RNA-seq analysis in HNSCC cells. The GSEA and PPI analysis were used to identify the pathways targeted for TBG-regulated genes. Meanwhile, the mechanism of TBG on anti-proliferative and anti-metastasis were investigated in vitro and in vivo. Results: The in vitro and in vivo experiments confirmed that TBG has favorable anti-tumor effects by induced G2/M phase arrest and suppressed metastasis in HNSCC cells. Further RNA-seq analysis demonstrated the genes regulated by TBG were enriched at the G2/M checkpoint and PLK1 signaling pathway. Then, the bioinformatic analysis of clinical data found that high expressed PLK1 were closely associated with poor overall survival in HNSCC patients. Furthermore, PLK1 directly and indirectly modulated G2/M phase and metastasis (by regulated CTCF) in HNSCC cells, simultaneously. TBG significantly inhibited the protein levels of PLK1 in both phosphorylated and non-phosphorylated forms and then, in one way, inactivated PLK1 failed to activate G2/M phase-related proteins (including CDK1, CDC25c, and cyclin B1). In another way, be inhibited PLK1 unable promote the nuclear translocation of CTCF and thus suppressed HNSC cell metastasis. In contrast, the anti-proliferative and anti-metastasis effects of TBG on HNSCC cell were vanished when cells high-expressed PLK1. Conclusion: The present study verified that PLK1 mediated TBG induced anti-tumor effect by modulated G2/M phase and metastasis in HNSCC cells.

Transferred Tumor suppressor BLU inhibits proliferation of nasopharyngeal carcinoma cells by regulation of cell cycle , JNK and cyclin D 1 promoters

Tumor Suppressor Blu Inhibits Proliferation of Nasopharyngeal Carcinoma Cells by Regulation of Cell Cycle, C-Jun N-Terminal Kinase and the Cyclin D1 Promoter

Research in the Relationship Between Chromosome 3p21.3, Tumor Suppressor Gene BLU and Nasopharyngeal Carcinoma

[Hypermethylation Status of Blu Gene in Nasopharyngeal Lymphoma].

Alterations of BLU, a Candidate Tumor Suppressor Gene on Chromosome 3p21.3, in Human Nasopharyngeal Carcinoma.

Lentivirus-mediated RNA Interference Targeting Bax Inhibitor-1 Suppresses Ex Vivo Cell Proliferation and in Vivo Tumor Growth of Nasopharyngeal Carcinoma.

Tumor suppressor PDCD4 modulates miR-184-mediated direct suppression of C-MYC and BCL2 blocking cell growth and survival in nasopharyngeal carcinoma

Inactivation Of Blu Is Associated With Methylation Of Sp1-Binding Site Of Blu Promoter In Gastric Cancer

Circ_BLNK is a Unique Molecular Marker in Non-small Cell Lung Cancer

The Tumor-Suppressor Gene Nkx2.8 Suppresses Bladder Cancer Proliferation Through Upregulation of FOXO3a and Inhibition of the MEK/ERK Signaling Pathway

Growth Suppression of Nasopharyngeal Carcinoma Cell Through Transfection of BRD7 Gene

Gene expression profile of THZ1-treated nasopharyngeal carcinoma cell lines indicates its involvement in the inhibition of the cell cycle

Stable Knockdown of ZBTB7A Promotes Cell Proliferation and Progression in Nasopharyngeal Carcinoma

Knockdown of C-Myc Inhibits Cell Proliferation by Negatively Regulating the Cdk/Rb/E2F Pathway in Nasopharyngeal Carcinoma Cells

TBX2 Over-Expression Promotes Nasopharyngeal Cancer Cell Proliferation and Invasion.

MicroRNA-188 Suppresses G 1 /S Transition by Targeting Multiple Cyclin/cdk Complexes

Suppression of Nasopharyngeal Carcinoma Cell by Targeting Β-Catenin Signaling Pathway.

Telocinobufagin, a PLK1 suppressor that inhibits tumor growth and metastasis by modulating CDC25c and CTCF in HNSCC cells

Transducin β-like 1 X-linked receptor 1 suppresses cisplatin sensitivity in Nasopharyngeal Carcinoma via activation of NF-κB pathway

Data from TNFRSF19 Inhibits TGFβ Signaling through Interaction with TGFβ Receptor Type I to Promote Tumorigenesis

The effect of transforming growth factor-β1 on nasopharyngeal carcinoma cells: insensitive to cell growth but functional to TGF-β/Smad pathway